Condition
Malignant Mesothelioma
Estimated Enrollment: 82
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: EORTC-08052|JJPRD-26866138CAN2012|2006-000009-51
Study First Received: April 9, 2007
Last Updated: April 19, 2013
Estimated Primary Completion Date: April 2010
Primary Outcome Measures:
Progression-free survival (PFS) rate at 18 weeks|Overall objective response rate|Symptomatic response rate|Safety as measured by NCI CTCAE v3.0 and the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity questionnaire|Duration of PFS|Overall survival
Sponsors and Collaborators:
European Organisation for Research and Treatment of Cancer – EORTC
Website Link: https://ClinicalTrials.gov/show/NCT00458913
